Ritonavir–PEG 8000Amorphous Solid Dispersions: In vitro and In vivo Evaluations
- 1 March 2004
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 93 (3) , 563-570
- https://doi.org/10.1002/jps.10566
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Melt extrusion: from process to drug delivery technologyPublished by Elsevier ,2002
- Prediction of Poly(Ethylene) Glycol-Drug Eutectic Compositions Using an Index Based on the van't Hoff EquationPharmaceutical Research, 2002
- Physicochemical considerations in the preparation of amorphous ritonavir–poly(ethylene glycol) 8000 solid dispersionsJournal of Pharmaceutical Sciences, 2001
- In vitro and in vivo evaluation of carbamazepine-PEG 6000 solid dispersionsInternational Journal of Pharmaceutics, 2001
- Solid dispersion of poorly water‐soluble drugs: Early promises, subsequent problems, and recent breakthroughsJournal of Pharmaceutical Sciences, 1999
- An Investigation of FB Interactions with Poly(ethylene glycol) 6000, Poly(ethylene glycol) 4000, and Poly-∈-caprolactone by Thermoanalytical and Spectroscopic Methods and ModelingJournal of Pharmaceutical Sciences, 1998
- Determination of ritonavir, a new HIV protease inhibitor, in biological samples using reversed-phase high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1997
- In Vitro Permeability Across Caco-2 Cells (Colonic) Can Predict In Vivo (Small Intestinal) Absorption in Man—Fact or MythPharmaceutical Research, 1997
- Caco-2 Cell Monolayers as a Model for Drug Transport Across the Intestinal MucosaPharmaceutical Research, 1990
- Dissolution Rates of High Energy Polyvinylpyrrolidone (PVP)-Sulfathiazole CoprecipitatesJournal of Pharmaceutical Sciences, 1969